These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 32835666)

  • 41. COVID-19 and Cardiovascular Disease: A Comprehensive Review.
    Khalil F; Oleszak F; Stys T; Stys A
    S D Med; 2022 Feb; 75(2):54-60. PubMed ID: 35704865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection.
    Rochette L; Ghibu S
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 and cardiovascular disease: a review of current knowledge.
    Pal A; Ahirwar AK; Sakarde A; Asia P; Gopal N; Alam S; Kaim K; Ahirwar P; Sorte SR
    Horm Mol Biol Clin Investig; 2021 Feb; 42(1):99-104. PubMed ID: 33544511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COVID-19 and cardiovascular disease.
    Guijarro C
    Clin Investig Arterioscler; 2020; 32(6):263-266. PubMed ID: 33213825
    [No Abstract]   [Full Text] [Related]  

  • 45. SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management.
    Wu L; O'Kane AM; Peng H; Bi Y; Motriuk-Smith D; Ren J
    Biochem Pharmacol; 2020 Aug; 178():114114. PubMed ID: 32579957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19.
    Möhlendick B; Schönfelder K; Breuckmann K; Elsner C; Babel N; Balfanz P; Dahl E; Dreher M; Fistera D; Herbstreit F; Hölzer B; Koch M; Kohnle M; Marx N; Risse J; Schmidt K; Skrzypczyk S; Sutharsan S; Taube C; Westhoff TH; Jöckel KH; Dittmer U; Siffert W; Kribben A
    Pharmacogenet Genomics; 2021 Oct; 31(8):165-171. PubMed ID: 34001841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential mechanisms of cerebrovascular diseases in COVID-19 patients.
    Lou M; Yuan D; Liao S; Tong L; Li J
    J Neurovirol; 2021 Feb; 27(1):35-51. PubMed ID: 33534131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
    Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
    Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities.
    Bienvenu LA; Noonan J; Wang X; Peter K
    Cardiovasc Res; 2020 Dec; 116(14):2197-2206. PubMed ID: 33063089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. COVID-19 and Cardiovascular Disease: From Bench to Bedside.
    Chung MK; Zidar DA; Bristow MR; Cameron SJ; Chan T; Harding CV; Kwon DH; Singh T; Tilton JC; Tsai EJ; Tucker NR; Barnard J; Loscalzo J
    Circ Res; 2021 Apr; 128(8):1214-1236. PubMed ID: 33856918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality.
    Aleksova A; Fluca AL; Gagno G; Pierri A; Padoan L; Derin A; Moretti R; Noveska EA; Azzalini E; D'Errico S; Beltrami AP; Zumla A; Ippolito G; Sinagra G; Janjusevic M
    Life Sci; 2022 Dec; 310():121018. PubMed ID: 36183780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coronavirus Disease 2019 and the Cerebrovascular-Cardiovascular Systems: What Do We Know So Far?
    Larson AS; Savastano L; Kadirvel R; Kallmes DF; Hassan AE; Brinjikji W
    J Am Heart Assoc; 2020 Jul; 9(13):e016793. PubMed ID: 32393136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review.
    Pepera G; Tribali MS; Batalik L; Petrov I; Papathanasiou J
    Rev Cardiovasc Med; 2022 Jan; 23(1):28. PubMed ID: 35092220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Centrality of Obesity in the Course of Severe COVID-19.
    Liu D; Zhang T; Wang Y; Xia L
    Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium.
    Kasela S; Ortega VE; Martorella M; Garudadri S; Nguyen J; Ampleford E; Pasanen A; Nerella S; Buschur KL; Barjaktarevic IZ; Barr RG; Bleecker ER; Bowler RP; Comellas AP; Cooper CB; Couper DJ; Criner GJ; Curtis JL; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Krishnan JA; Martinez FJ; McDonald MN; Meyers DA; Paine R; Peters SP; Castro M; Denlinger LC; Erzurum SC; Fahy JV; Israel E; Jarjour NN; Levy BD; Li X; Moore WC; Wenzel SE; Zein J; ; ; Langelier C; Woodruff PG; Lappalainen T; Christenson SA
    Genome Med; 2021 Apr; 13(1):66. PubMed ID: 33883027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh.
    Sharif N; Ahmed SN; Opu RR; Tani MR; Dewan D; Daullah MU; Shanto RI; Parvez AK; Talukder AA; Dey SK
    Diabetes Metab Syndr; 2021; 15(3):1009-1016. PubMed ID: 33993046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Androgens, the kidney, and COVID-19: an opportunity for translational research.
    Yanes Cardozo LL; Rezq S; Pruett JE; Romero DG
    Am J Physiol Renal Physiol; 2021 Feb; 320(2):F243-F248. PubMed ID: 33464168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations.
    Shu H; Wen Z; Li N; Zhang Z; Ceesay BM; Peng Y; Zhou N; Wang DW
    Aging Dis; 2023 Dec; 14(6):2071-2088. PubMed ID: 37199573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment.
    Luo J; Zhu X; Jian J; Chen X; Yin K
    Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):273-282. PubMed ID: 33428706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.
    Hendren NS; Drazner MH; Bozkurt B; Cooper LT
    Circulation; 2020 Jun; 141(23):1903-1914. PubMed ID: 32297796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.